Publicaciones en las que colabora con José Manuel Olivares Díez (16)

2024

  1. Functioning in schizophrenia: Recommendations of an expert panel

    Schizophrenia Research, Vol. 270, pp. 317-322

2021

  1. Early intervention services, patterns of prescription and rates of discontinuation of antipsychotic treatment in first-episode psychosis

    Early Intervention in Psychiatry, Vol. 15, Núm. 6, pp. 1584-1594

2019

  1. CIBERSAM: Ten years of collaborative translational research in mental disorders

    Revista de Psiquiatria y Salud Mental, Vol. 12, Núm. 1, pp. 1-8

  2. Long-acting injectable antipsychotics for the treatment of schizophrenia in Spain

    Revista de Psiquiatria y Salud Mental, Vol. 12, Núm. 2, pp. 92-105

2017

  1. Efficacy of prospective pharmacogenetic testing in the treatment of major depressive disorder: Results of a randomized, double-blind clinical trial

    BMC Psychiatry, Vol. 17, Núm. 1

  2. Eficacia, eficiencia y efectividad en el tratamiento multidimensional de la esquizofrenia: proyecto Rethinking

    Revista de Psiquiatria y Salud Mental, Vol. 10, Núm. 1, pp. 4-20

2015

  1. Clinical and economic outcomes of adjunctive therapy with pregabalin or usual care in generalized anxiety disorder patients with partial response to selective serotonin reuptake inhibitors

    Annals of General Psychiatry, Vol. 14, Núm. 1

  2. Modeling the longitudinal latent effect of pregabalin on self-reported changes in sleep disturbances in outpatients with generalized anxiety disorder managed in routine clinical practice

    Drug Design, Development and Therapy, Vol. 9, pp. 4329-4340

  3. Pregabalin for the treatment of patients with generalized anxiety disorder with inadequate treatment response to antidepressants and severe depressive symptoms

    International Clinical Psychopharmacology, Vol. 30, Núm. 5, pp. 265-271

2013

  1. A comparative cost-analysis of initiating pregabalin or SSRI/SNRI therapy in benzodiazepine-resistant patients with generalized anxiety disorder in Spain

    Actas Espanolas de Psiquiatria, Vol. 41, Núm. 3, pp. 164-174

  2. Modelling the cost-effectiveness of pregabalin versus usual care in daily practice in the treatment of refractory generalised anxiety disorder in Spain

    Social Psychiatry and Psychiatric Epidemiology, Vol. 48, Núm. 6, pp. 985-996

2012

  1. Broadening of generalized anxiety disorders definition does not affect the response to psychiatric care: Findings from the observational ADAN study

    Clinical Practice and Epidemiology in Mental Health, Vol. 8, pp. 158-168

  2. Pregabalin versus SSRIs and SNRIs in benzodiazepine-refractory outpatients with generalized anxiety disorder: A post hoc cost-effectiveness analysis in usual medical practice in Spain

    ClinicoEconomics and Outcomes Research, Vol. 4, Núm. 1, pp. 157-168

2005

  1. A 6-month prospective observational study on the effects of quetiapine on sexual functioning

    Journal of Clinical Psychopharmacology, Vol. 25, Núm. 6, pp. 533-538

2003

  1. Escala GEOPTE de cognición social para la psicosis: GEOPTE (Grupo Español para la Optimización y Tratamiento de la Esquizofrenia)

    Actas Espanolas de Psiquiatria, Vol. 31, Núm. 3, pp. 120-128

2001

  1. Incidence of extrapyramidal symptoms during treatment with olanzapine, haloperidol and risperidone: Results of an observational study (EFESO study)

    Actas Espanolas de Psiquiatria, Vol. 29, Núm. 1, pp. 25-32